1、Lallemand-Breitenbach V, Zhu J, Chen Z and de The H.. Curing APL through PML/RARA degradation by As2O3. Trends in Molecular Medicine,2012;18:1-4
2、Yuan H, Zhou J, Deng M, Zhang Y, Chen Y, Jin Y, Zhu J, Chen SJ, de The H, Chen Z, Liu TX, Zhu J#. Sumoylation of CCAAT/enhancer-binding protein α promotes the biased primitive hematopoiesis of zebrafish.. Blood,2011;117(26):7014-20
3、Yuan H, Zhou J, Deng M, Liu X, Le Bras M, de Thé H, Chen SJ, Chen Z, Liu TX,Zhu J#. Small ubiquitin-related modifier paralogs are indispensable but functionally redundant during early development of zebrafish. Cell Res,2010;20(2):185-96.
4、Nasr R, Lallemand-Breitenbach V, Zhu J, Guillemin MC and de Thé H. . Therapy-induced PML/RARA Proteolysis and Acute Promyelocytic Leukemia Cure. Clin Cancer Res,2009;15(20):6321-6325
5、Nasr R, Guillemin MC, Ferhi O, Soilihi H, Peres L, Berthier C, Rousselot P, Robledo-Sarmiento M, Lallemand-Breitenbach V, Gourme B, Vitoux D, Pandolfi PP, Rochette-Egly C, Zhu J,de Thé H. APL leukemia initiating cell eradication through cooperative cAMP- RA- and arsenic-triggered PML/RARA degradation. Nature Medecine,2008;14(12):1333-42
6、Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, Zhou J, Zhu J, Raught B,de Thé H. . Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol,2008;10(5):547-55.
7、Zhu J*, Nasr R, Peres L, Riaucoux F, Honore N, Berthier C, Kamashev D, Zhou J, Lavau C, Gronmeyer H and de Thé H.. RXR is an essential component of the oncogenic PML/RARA complex in vivo. Cancer Cell,2007;12(1):23-35.
8、Zhou J, Peres L, Honore N, Nasr R, Zhu J#,de Thé H. Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization.. Proc Natl Acad Sci U S A,2006;103(24):9238-43.
9、Condamine W, Takahashi Y, Zhu J, Puvion-Dutilleul F, Guegan S, Janin A and de The H. Characterization of endogenous human promyelocytic leukemia isoforms.. Cancer Res.,2006;66(12):6192-8.
10、Lallemand V, Zhu J , Chen Z and De Thé H. From mice to patients: lessons from the APL model. Nature Review Cancer,2005;5:821-827
11、Zhu J*, Zhou J, Peres L, Riaucoux F, Honore N, Kogan SC and De Thé H.. PML/RAR Sumolation is essential for leukemic transformation.. Cancer Cell,2005;7:143-153
|
